For Gundbert Scherf — the co-founder of Germany’s Helsing, Europe’s most valuable defence start-up — Russia’s invasion of ...

AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.

Palantir (NASDAQ:PLTR) is a colossal winner that’s just found a way to keep winning in 2025. With shares up more than 37% in ...

Companies of all kinds, from retailers to advertising and recruitment firms, are now starting to embrace AI in efforts to ...

For all the talk about the lofty valuation of Palantir stock, backers of the artificial-intelligence heavyweight aren’t ...

Palantir has more than doubled in value this year as investors ramp up bets on the company’s artificial intelligence business ...

Klarna, the Swedish fintech known for its "Buy Now, Pay Later" (BNPL) services, has been making significant strides to ...

America’s AI Action Plan,” unveiled at a Hill & Valley conference, outlined three pillars to secure US dominance in the ...

Donald Trump's administration introduced an AI Action Plan. The plan focuses on reducing regulations and boosting technology ...

Tech companies selling AI to the federal government now face a new challenge: proving their chatbots aren't "woke." President ...